Publication:
Comorbidity and polypharmacy in chronic heart failure: a large cross-sectional study in primary care.

No Thumbnail Available

Date

2017-04-10

Authors

Baron-Franco, Bosco
McLean, Gary
Mair, Frances S
Roger, Veronique L
Guthrie, Bruce
Mercer, Stewart W

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Comorbidity is common in heart failure, but previous prevalence estimates have been based on a limited number of conditions using mainly non-primary care data sources. To compare prevalence rates of comorbidity and polypharmacy in those with and without chronic heart failure due to left ventricular systolic dysfunction (LVSD). A cross-sectional study of 1.4 million patients in primary care in Scotland. Data on the presence of LVSD, 31 other physical, and seven mental health comorbidities, and prescriptions were extracted from a database of 1 424 378 adults. Comorbidity prevalence was compared in patients with and without LVSD, standardised by age, sex, and deprivation. Pharmacology data were also compared between the two groups. There were 17 285 patients (1.2%) who had a diagnosis of LVSD. Compared with standardised controls, the LVSD group had greater comorbidity, with the biggest difference found for seven or more conditions (odds ratio [OR] 4.10; 95% confidence interval (CI] = 3.90 to 4.32). Twenty-five physical conditions and six mental health conditions were significantly more prevalent in those with LVSD relative to standardised controls. Polypharmacy was higher in the LVSD group compared with controls, with the biggest difference found for ≥11 repeat prescriptions (OR 4.81; 95% CI = 4.60 to 5.04). However, these differences in polypharmacy were attenuated after controlling for the number of morbidities, indicating that much of the additional prescribing was accounted for by multimorbidity rather than LVSD per se. Extreme comorbidity and polypharmacy is significantly more common in patients with chronic heart failure due to LVSD. The efficient management of such complexity requires the integration of general and specialist expertise.

Description

MeSH Terms

Adolescent
Adult
Age Distribution
Aged
Aged, 80 and over
Chronic Disease
Cross-Sectional Studies
Drug Prescriptions
Female
Health Status
Heart Failure
Humans
Male
Mental Disorders
Middle Aged
Polypharmacy
Scotland
Socioeconomic Factors
Ventricular Dysfunction, Left
Young Adult

DeCS Terms

CIE Terms

Keywords

comorbidity, general practice, heart failure, multimorbidity, polypharmacy

Citation